PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus
- Authors
- Lee, JM; Kang, HJ; Lee, HR; Choi, CY; Jang, WJ; Ahn, JH
- Issue Date
- 4-12월-2003
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- human cytomegalovirus; immediate-early protein; protein inhibitor ofactivated STAT1; small ubiquitin-like modifier-1
- Citation
- FEBS LETTERS, v.555, no.2, pp.322 - 328
- Indexed
- SCIE
SCOPUS
- Journal Title
- FEBS LETTERS
- Volume
- 555
- Number
- 2
- Start Page
- 322
- End Page
- 328
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/124346
- DOI
- 10.1016/S0014-5793(03)01268-7
- ISSN
- 0014-5793
- Abstract
- The protein inhibitor of activated STAT1 (PIAS1), known to be a small ubiquitin-like modifier (SUMO) E3 ligase, was found to interact with the human cytomegalovirus IE2 protein. We found that the sumoylation of IE2 was markedly enhanced by wild-type PIAS1 but not by a mutant containing a Cys to Ser substitution at position 351 (C351S) within the RING finger-like domain. In target reporter gene assays, wild-type PIAS1, but not the C351S mutant, enhanced the IE2-mediated transactivations of viral polymerase promoter and cellular cyclin E promoter and this augmentation required the intact sumoylation sites of IE2. Our results suggest that PIAS1 acts as a SUMO E3 ligase toward IE2 and that it may regulate the transactivation function of IE2. To our knowledge, IE2 is the first viral target found to be regulated by a SUMO E3 ligase. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biotechnology and Bioinformatics > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.